eli lilly and company

News

Eli Lilly raises price of Mounjaro obesity drug

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy called "most favored nation."

The Wall Street Journal on MSN · 12h

Eli Lilly to Raise U.K. Price of Mounjaro for Out-of-Pocket Patients

Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug Mounjaro, so that it can comply with the Trump administration’s goal of bringing down prices in the U.S.

Hosted on MSN · 13h

Eli Lilly hikes UK price of weight loss drug Mounjaro by up to 170%

Eli Lilly has raised the UK price of its popular weight loss drug Mounjaro by as much as 170 per cent, as it tries to address complaints by Donald Trump’s administration about “foreign freeloaders” who rely on the US to pay more for medicines.

Eli Lilly, AI and Superluminal

Fast Company · 12h

Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines

Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven platform.

Yahoo Finance · 13h

C3.ai downgrade, Oracle–Alphabet deal, Eli Lilly & Superluminal

Yahoo Finance anchor Julie Hyman tracks Thursday's top stocks and market movers in this Market Minute. C3.ai (AI) stock dips after Oppenheimer downgraded the stock to Perform from Outperform, citing weak preliminary first quarter results.

Seeking Alpha on MSN · 8h

Eli Lilly partners with AI healthtech Superluminal Medicines

Superluminal Medicines, a healthcare company integrating AI/ML, announced partnership with Eli Lilly (NYSE:LLY) to advance small molecule therapeutics targeting cardiometabolic diseases and obesity. Under the deal,

10h

Oracle, Eli Lilly, Terawulf: Trending Tickers

Oracle (ORCL) stock is in focus on reports that the company will cut jobs in its cloud division — part of a broader push to ...

12hon MSN

Eli Lilly and Company (LLY): “Wall Street Was Really Wrong,” Says Jim Cramer

We recently published 10 Stocks On Jim Cramer’s Radar Including Big Tech Firms. Eli Lilly and Company (NYSE:LLY) is one of ...

1don MSN

Eli Lilly insider buying from CEO and others jump amid selloff

Eli Lilly (LLY) stock recovers as company executives seize a rare buying opportunity to make a series of insider purchases ...

Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Its Medications

WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" ...

1don MSN

Jim Cramer on Eli Lilly Stock: “It Just Got Pole-Axed, Laid to Waste”

Last and least, I look at the drug stocks and I can’t believe how awful they really are, with now Eli Lilly last joining the ...

Texas Sues Eli Lilly: 'Big Pharma Compromised Medical Decision-Making'

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...

7don MSN

Eli Lilly weight loss pill shows promise in latest clinical trial, company says

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

24/7 Wall St.2d

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Aug 2025)

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Click here to read an analysis of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results